ERNIE METH, M.D.
Nuclear Medicine Physician · MURRIETA, CA
Individual Active NPI 1972548188
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 130 | 12,282 | $4,140,315 | $3,082,892 | $2,455,050 |
| 2023 | 117 | 9,624 | $2,902,914 | $2,129,446 | $1,694,834 |
| 2022 | 114 | 2,892 | $888,533 | $669,431 | $533,006 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 397 | $1,054 | $840 |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | 99 | $115 | $89 |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 76 | $1,740 | $1,386 |
| 79101 | Radioactive drug therapy through a vein | 57 | $160 | $123 |
| 99215 | Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 43 | $178 | $131 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 18 | $353 | $281 |
| 78608 | Nuclear medicine study of brain with metabolic evaluation | 14 | $1,688 | $1,345 |
| A9561 | Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries | 13 | $49 | $39 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Nuclear Medicine Physician | 207U00000X | ✓ | A41717 | CA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Nuclear Medicine Physician providers in California
- NPI 1093798720
- NPI 1669868857
- NPI 1093886988
- NPI 1558674374
- NPI 1710262472
- NPI 1902442650
- NPI 1063590776
- NPI 1609239532
See all Nuclear Medicine Physician providers in California →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.